ESC Premium Access

Temporal trends in first-line anticoagulation therapy for cancer-associated venous thromboembolism

Congress Presentation

About the speaker

Mr Jackson King

Spokane (United States of America)
0 follower

10 more presentations in this session

Determinants of the use of direct oral anticoagulants in acute pulmonary thromboembolism in argentina

Speaker: Mr M. Bernal (Buenos Aires, AR)


Predictors for not initiating anticoagulant treatment after incident venous thromboembolism: a Danish nationwide study

Speaker: Doctor I. Albertsen (Aalborg, DK)


Elevated D-dimer level after 1 month anticoagulant therapy as a predictor for adverse outcomes in patients with venous thromboembolism: 10-year follow-up results

Speaker: Doctor N. Vorobyeva (Moscow, RU)


Early versus delayed oral anticoagulation in patients with acute pulmonary embolism: determinants and outcome.

Speaker: Doctor C. Becattini (Perugia, IT)


Patterns of extended apixaban treatment for unprovoked venous thromboembolism in routine clinical practice

Speaker: Doctor X. Luo (Groton, US)


Access the full session

Poster Session 6 - Acute and anticoagulation

Speakers: Mr J. King, Mr M. Bernal, Doctor I. Albertsen, Doctor N. Vorobyeva, Doctor C. Becattini...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb